Characterizing and testing the efficacy of AAV-mediated gene therapy in a novel CRISPR/Cas9 generated sheep model of Cln1 disease

Project Details

StatusFinished
Effective start/end date1/07/21 → 30/06/22

Funding

  • Non-EU other: £115,921.00